Skip to main content
Top
Published in: European Journal of Medical Research 1/2021

Open Access 01-12-2021 | Irritable Bowel Syndrome | Research

Cytokines in the colon, central nervous system and serum of irritable bowel syndrome rats

Authors: Guanqun Chao, Zhaojun Wang, Xinli Chen, Shuo Zhang

Published in: European Journal of Medical Research | Issue 1/2021

Login to get access

Abstract

Objective

The aim of this study was to detect the expression of interleukin (IL)-1β and transforming growth factor (TGF)-β1 in the colonic tissue and serum of irritable bowel syndrome (IBS) rats, as well as the distribution and expression of corticotropin-releasing factor (CRF) in the spinal cord and brain of the visceral hypersensitivity rats, thus to ascertain the mechanism of visceral hypersensitivity signal conduction pathway.

Methods

The expression of IL-1β and TGF-β1 in the colonic tissue and serum of IBS rats was screened by the liquid chip technology and verified by RT-PCR technology. Then the quantitative analysis of CRF in the spinal cord and brain was achieved by the immunohistochemical method and computerized image system.

Result

The rat model with visceral hypersensitivity was successfully established. Among the screened indicators of IL-1β and TGF-β1 in colon tissue and serum, only the expression of IL-1β in the model group was up-regulated (P < 0.05). The immunohistochemical method showed that CRF was expressed in the spinal cord, hypothalamus, and the third ventricle. The positive index number of the model groups was higher than that of the control group (P < 0.01).

Conclusion

From the research, it can be inferred that IL-1β may participate in the pathogenesis mechanism of IBS via regulating the colon function. The increasing expression of CRF linked to stress in the spinal cord, hypothalamus and the third ventricle indicated that it might play an important role in the mechanisms of visceral hypersensitivity signal conduction pathway.
Literature
1.
go back to reference Xu XJ, Liu L, Yao SK. Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target? J Zhejiang Univ Sci B. 2016;17:1–9.CrossRef Xu XJ, Liu L, Yao SK. Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target? J Zhejiang Univ Sci B. 2016;17:1–9.CrossRef
2.
go back to reference Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10:712–21.CrossRef Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10:712–21.CrossRef
3.
go back to reference Chang FY, Lu CL, Chen TS. The current prevalence of irritable bowel syndrome in Asia. J Neurogastroenterol Motil. 2010;16:389–400.CrossRef Chang FY, Lu CL, Chen TS. The current prevalence of irritable bowel syndrome in Asia. J Neurogastroenterol Motil. 2010;16:389–400.CrossRef
4.
go back to reference Zhou Q, et al. Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1. Gut. 2016;65:797–805.CrossRef Zhou Q, et al. Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1. Gut. 2016;65:797–805.CrossRef
5.
go back to reference Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313:949–58.CrossRef Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313:949–58.CrossRef
6.
go back to reference Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010;7:163–73.CrossRef Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010;7:163–73.CrossRef
7.
go back to reference Troncone E, Marafini I, Stolfi C, Monteleone G. Transforming growth factor-β1/Smad7 in intestinal immunity, inflammation, and cancer. Front Immunol. 2018;9:1407.CrossRef Troncone E, Marafini I, Stolfi C, Monteleone G. Transforming growth factor-β1/Smad7 in intestinal immunity, inflammation, and cancer. Front Immunol. 2018;9:1407.CrossRef
8.
go back to reference Baser U, et al. Gingival inflammation and interleukin-1 beta and tumor necrosis factor-alpha levels in gingival crevicular fluid during the menstrual cycle. J Periodontol. 2009;80:1983–90.CrossRef Baser U, et al. Gingival inflammation and interleukin-1 beta and tumor necrosis factor-alpha levels in gingival crevicular fluid during the menstrual cycle. J Periodontol. 2009;80:1983–90.CrossRef
9.
go back to reference Hussain Z, Kim HW, Huh CW, Lee YJ, Park H. the effect of peripheral CRF peptide and water avoidance stress on colonic and gastric transit in guinea pigs. Yonsei Med J. 2017;58:872–7.CrossRef Hussain Z, Kim HW, Huh CW, Lee YJ, Park H. the effect of peripheral CRF peptide and water avoidance stress on colonic and gastric transit in guinea pigs. Yonsei Med J. 2017;58:872–7.CrossRef
10.
go back to reference Chao G, Zhang S. Aquaporins 1, 3 and 8 expression in irritable bowel syndrome rats colon via NF-κB pathway. Oncotarget. 2017;8:47175–83.CrossRef Chao G, Zhang S. Aquaporins 1, 3 and 8 expression in irritable bowel syndrome rats colon via NF-κB pathway. Oncotarget. 2017;8:47175–83.CrossRef
11.
go back to reference El-Salhy M, Hatlebakk JG, Hausken T. Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS). Neuropeptides. 2019;79:e101973.CrossRef El-Salhy M, Hatlebakk JG, Hausken T. Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS). Neuropeptides. 2019;79:e101973.CrossRef
12.
go back to reference Oshima T, Miwa H. Epidemiology of functional gastrointestinal disorders in Japan and in the World. J Neurogastroenterol Motil. 2015;21:320–9.CrossRef Oshima T, Miwa H. Epidemiology of functional gastrointestinal disorders in Japan and in the World. J Neurogastroenterol Motil. 2015;21:320–9.CrossRef
13.
go back to reference Herndon CC, Wang YP, Lu CL. Targeting the gut microbiota for the treatment of irritable bowel syndrome. Kaohsiung J Med Sci. 2020;36:160–70.CrossRef Herndon CC, Wang YP, Lu CL. Targeting the gut microbiota for the treatment of irritable bowel syndrome. Kaohsiung J Med Sci. 2020;36:160–70.CrossRef
14.
go back to reference Rej A, Aziz I, Tornblom H, Sanders DS, Simrén M. The role of diet in irritable bowel syndrome: implications for dietary advice. J Intern Med. 2019;2:e12966. Rej A, Aziz I, Tornblom H, Sanders DS, Simrén M. The role of diet in irritable bowel syndrome: implications for dietary advice. J Intern Med. 2019;2:e12966.
15.
go back to reference Yang B, Zhou X, Lan C. Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome. BMC Gastroenterol. 2015;15:43.CrossRef Yang B, Zhou X, Lan C. Changes of cytokine levels in a mouse model of post-infectious irritable bowel syndrome. BMC Gastroenterol. 2015;15:43.CrossRef
16.
go back to reference Spiller RC, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47:804–11.CrossRef Spiller RC, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47:804–11.CrossRef
17.
go back to reference Gao J. Correlation between anxiety-depression status and cytokines in diarrhea-predominant irritable bowel syndrome. Exp Ther Med. 2013;6:93–6.CrossRef Gao J. Correlation between anxiety-depression status and cytokines in diarrhea-predominant irritable bowel syndrome. Exp Ther Med. 2013;6:93–6.CrossRef
18.
go back to reference Belmonte L, et al. Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype. PLoS ONE. 2012;7:e42777.CrossRef Belmonte L, et al. Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype. PLoS ONE. 2012;7:e42777.CrossRef
19.
go back to reference Bashashati M, et al. Cytokines and irritable bowel syndrome: where do we stand? Cytokine. 2012;57:201–9.CrossRef Bashashati M, et al. Cytokines and irritable bowel syndrome: where do we stand? Cytokine. 2012;57:201–9.CrossRef
20.
go back to reference Bashashati M, et al. Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil. 2014;26:1036–48.CrossRef Bashashati M, et al. Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil. 2014;26:1036–48.CrossRef
21.
go back to reference Stadnicki A, Machnik G, Klimacka-Nawrot E, Wolanska-Karut A, Labuzek K. Transforming growth factor-beta1 and its receptors in patients with ulcerative colitis. Int Immunopharmacol. 2009;9:761–6.CrossRef Stadnicki A, Machnik G, Klimacka-Nawrot E, Wolanska-Karut A, Labuzek K. Transforming growth factor-beta1 and its receptors in patients with ulcerative colitis. Int Immunopharmacol. 2009;9:761–6.CrossRef
22.
go back to reference Sun X, Lan C. Study on the expression of Runx3 and TGF-β1 protein in the colonic tissue from rats with irritable bowel syndrome. Asian Pac J Trop Med. 2011;4:88–91.CrossRef Sun X, Lan C. Study on the expression of Runx3 and TGF-β1 protein in the colonic tissue from rats with irritable bowel syndrome. Asian Pac J Trop Med. 2011;4:88–91.CrossRef
23.
go back to reference Gonsalkorale WM, Perrey C, Pravica V, Whorwell PJ, Hutchinson IV. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut. 2003;52:91–3.CrossRef Gonsalkorale WM, Perrey C, Pravica V, Whorwell PJ, Hutchinson IV. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut. 2003;52:91–3.CrossRef
24.
go back to reference Normandeau CP, et al. A key role for neurotensin in chronic-stress-induced anxiety-like behavior in rats. Neuropsychopharmacology. 2018;43:285–93.CrossRef Normandeau CP, et al. A key role for neurotensin in chronic-stress-induced anxiety-like behavior in rats. Neuropsychopharmacology. 2018;43:285–93.CrossRef
25.
go back to reference Aisenberg N, Serova L, Sabban EL, Akirav I. The effects of enhancing endocannabinoid signaling and blocking corticotrophin releasing factor receptor in the amygdala and hippocampus on the consolidation of a stressful event. Eur Neuropsychopharmacol. 2017;27:913–27.CrossRef Aisenberg N, Serova L, Sabban EL, Akirav I. The effects of enhancing endocannabinoid signaling and blocking corticotrophin releasing factor receptor in the amygdala and hippocampus on the consolidation of a stressful event. Eur Neuropsychopharmacol. 2017;27:913–27.CrossRef
26.
go back to reference Czimmer J, Tache Y. Peripheral corticotropin releasing factor signaling inhibits gastric emptying: mechanisms of action and role in stress-related gastric alterations of motor function. Curr Pharm Des. 2017;23:4042–7.CrossRef Czimmer J, Tache Y. Peripheral corticotropin releasing factor signaling inhibits gastric emptying: mechanisms of action and role in stress-related gastric alterations of motor function. Curr Pharm Des. 2017;23:4042–7.CrossRef
27.
go back to reference Kim KJ, et al. Corticotropin-releasing factor stimulates colonic motility via muscarinic receptors in the rat. World J Gastroenterol. 2017;23:3825–31.CrossRef Kim KJ, et al. Corticotropin-releasing factor stimulates colonic motility via muscarinic receptors in the rat. World J Gastroenterol. 2017;23:3825–31.CrossRef
28.
go back to reference Stengel A, Taché Y. Neuroendocrine control of the gut during stress: corticotropin-releasing factor signaling pathways in the spotlight. Annu Rev Physiol. 2009;71:219–39.CrossRef Stengel A, Taché Y. Neuroendocrine control of the gut during stress: corticotropin-releasing factor signaling pathways in the spotlight. Annu Rev Physiol. 2009;71:219–39.CrossRef
29.
go back to reference Fukudo S. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol. 2007;42:48–51.CrossRef Fukudo S. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol. 2007;42:48–51.CrossRef
Metadata
Title
Cytokines in the colon, central nervous system and serum of irritable bowel syndrome rats
Authors
Guanqun Chao
Zhaojun Wang
Xinli Chen
Shuo Zhang
Publication date
01-12-2021
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2021
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-021-00479-w

Other articles of this Issue 1/2021

European Journal of Medical Research 1/2021 Go to the issue